EAST HANOVER, N.J., March 23, 2022 — Novartis announced today that the US Food and Drug Administration (FDA) approved Locametz® (kit for the preparation of gallium Ga 68 gozetotide injection)2. After radiolabeling, this imaging agent may be…Original Article
FDA Approves Locametz (kit for the preparation of gallium Ga 68 gozetotide injection) for PSMA PET Imaging in Patients with Prostate Cancer
